- Home
- FNLC vs JUNS Comparison
FNLC vs JUNS Comparison
Compare FNLC & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNLC
- JUNS
- Stock Information
- Founded
- FNLC 1864
- JUNS 2015
- Country
- FNLC United States
- JUNS United States
- Employees
- FNLC N/A
- JUNS N/A
- Industry
- FNLC Major Banks
- JUNS
- Sector
- FNLC Finance
- JUNS
- Exchange
- FNLC Nasdaq
- JUNS NYSE
- Market Cap
- FNLC 284.1M
- JUNS 281.4M
- IPO Year
- FNLC 1999
- JUNS 2024
- Fundamental
- Price
- FNLC $24.81
- JUNS $0.61
- Analyst Decision
- FNLC
- JUNS
- Analyst Count
- FNLC 0
- JUNS 0
- Target Price
- FNLC N/A
- JUNS N/A
- AVG Volume (30 Days)
- FNLC 18.6K
- JUNS 144.5K
- Earning Date
- FNLC 04-16-2025
- JUNS 05-11-2025
- Dividend Yield
- FNLC 5.80%
- JUNS N/A
- EPS Growth
- FNLC N/A
- JUNS N/A
- EPS
- FNLC 2.43
- JUNS N/A
- Revenue
- FNLC $79,740,000.00
- JUNS N/A
- Revenue This Year
- FNLC N/A
- JUNS N/A
- Revenue Next Year
- FNLC N/A
- JUNS N/A
- P/E Ratio
- FNLC $10.21
- JUNS N/A
- Revenue Growth
- FNLC 0.35
- JUNS N/A
- 52 Week Low
- FNLC $21.77
- JUNS $0.55
- 52 Week High
- FNLC $31.05
- JUNS $19.51
- Technical
- Relative Strength Index (RSI)
- FNLC 41.38
- JUNS N/A
- Support Level
- FNLC $24.34
- JUNS N/A
- Resistance Level
- FNLC $26.38
- JUNS N/A
- Average True Range (ATR)
- FNLC 0.57
- JUNS 0.00
- MACD
- FNLC -0.09
- JUNS 0.00
- Stochastic Oscillator
- FNLC 23.04
- JUNS 0.00
About FNLC First Bancorp Inc (ME)
First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services including deposit accounts and consumer, commercial and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.